NEJM: Peer-reviewed data suggests remdesivir shortens COVID-
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Preliminary data from a peer-reviewed clinical trial found that Gilead Sciences’ drug remdesivir shortened the recovery time in patients with Covid-19, according to a report published on 23 May in the New England Journal of Medicine.

Key Findings:

• The double-blind, randomized trial found that patients taking remdesivir had a median recovery time of 11 days compared to 15 days for those taking a placebo.

• Remdesivir was most beneficial for patients with severe disease who are in need of additional oxygen, while results from other patient subgroups were less conclusive.

• Preliminary results for the trial were previously released by the National Institutes of Health on April 29, and on May 1 the Food and Drug Administration granted emergency use authorization for remdesivir to be used to treat coronavirus.

• But its effectiveness has not been conclusively proven: another, smaller study from China, published in The Lancet, found no statistically significant improvement in recovery time.

• The new paper also states that given the high mortality rate of patients treated with remdesivir, treatment with an antiviral drug alone is not likely to be sufficient.

The FDA’s emergency use authorization of remdesivir does not mean that the agency has approved the drug, but doctors can give it to patients as scientists continue to study it. Though it’s still unproven, remdesivir has more clinical data behind it than hydroxychloroquine.

Source: https://www.nejm.org/doi/full/10.1056/NEJMoa2007764
J●y P●●●●r and 10 others like this6 shares
Like
Comment
Share
Dr. S●●●●●m S●●●●y P●●●●●l
Dr. S●●●●●m S●●●●y P●●●●●l General Medicine
Pardon me for being biased,and not wishing to doubt the authenticity of anything published in the Lancet,but any information coming out of China,needs to be distrusted until proven otherwise.
May 26, 2020Like2